People

Julie Cherrington

Julie Cherrington is non-executive director of listed investment company Syncona Limited. Biotechnology executive experienced in oncology development and company leadership across North America and Australia. Trained in microbiology and immunology at Minnesota and Stanford. Julie Cherrington is venture partner - usa at Brandon Capital. Her2022 Brandon venture-partner appointment adds extensive oncology and biotechnology operating experience. Her career includes leadership at QUE, Arch, Revitope, Zenith and Pathway, with earlier research management at SUGEN and Gilead. Existing Syncona directorships and authentic portrait are preserved. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.